www.fdanews.com/articles/149367-fda-to-fast-track-atox-bio-rsquo-s-flesh-eating-bacteria-treatment
FDA to Fast Track Atox Bio’s Flesh-Eating Bacteria Treatment
September 11, 2012
Israeli biotechnology firm Atox Bio said the FDA has granted fast track designation to AB103, its product in development for the treatment of necrotizing soft tissue infections, also known as flesh-eating bacteria.
Reuters
Reuters